Related Experiment Videos
[Drug induced hemolytic uremic syndrome]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 1, 1993
Summary
Certain drugs, including chemotherapy agents and immunosuppressants, can trigger hemolytic uremic syndrome (HUS). While cancer-associated HUS has a poor prognosis, drug-induced HUS from quinine or cocaine may resolve.
Area of Science:
- Pharmacology
- Nephrology
- Oncology
Context:
- Hemolytic uremic syndrome (HUS) is a serious condition.
- Various medications are implicated in HUS development.
Purpose:
- To review drugs known to induce HUS.
- To highlight the varying prognoses of different drug-induced HUS types.
Summary:
- Antineoplastic drugs like Mitomycin C (MMC), vinblastine, bleomycin, and cisplatin can induce HUS.
- Immunosuppressants such as cyclosporine and FK506 are also associated with HUS.
- Noncardiogenic pulmonary edema is a frequent complication of MMC-induced HUS.
- Quinine and cocaine can also cause HUS, with potentially better outcomes than cancer-associated HUS.
Impact:
- Understanding drug-induced HUS is crucial for patient management.
- Highlights the need for vigilance in patients receiving causative medications.
- Emphasizes the poor prognosis of cancer-associated HUS and the lack of established therapies.